Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock

被引:51
作者
Caille, V
Chiche, JD
Nciri, N
Berton, C
Gibot, S
Boval, B
Payen, D
Mira, JP
Mebazaa, A
机构
[1] Univ Paris 07, Larboisiere Univ Hosp, Dept Anesthesiol & Crit Care Med, F-75475 Paris 10, France
[2] Univ Paris 07, Larboisiere Univ Hosp, Hematol Lab, F-75475 Paris 10, France
[3] Univ Paris 06, St Vincent Paul Univ Hosp, Med Intens Care Unit, Paris, France
[4] Univ Paris 06, St Vincent Paul Univ Hosp, Inst Cochin Genet Mol, Paris, France
来源
SHOCK | 2004年 / 22卷 / 06期
关键词
sepsis; septic shock; cardiogenic shock; hemorrhagic shock; monocytes; HLA-DR antigens; flow cytometry;
D O I
10.1097/01.shk.0000143410.63698.57
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although the expression of monocyte histocompatibility leukocyte antigen (HLA)-DR has been shown to be decreased during human sepsis, its level of expression in other nonseptic critical conditions is unclear. The aim of this study was to compare the level of HLA-DR expression on circulating monocytes among patients with septic, hemorrhagic, and cardiogenic shocks and severe sepsis without shock. At admission, HLA-DR expression was exclusively decreased in patients with septic shock (n = 30; P < 0.001), whereas the expression was similar between the other studied groups: cardiogenic shock (n = 16), hemorrhagic shock (n = 11), severe sepsis without shock (n = 18), and healthy volunteers (n = 8). HLA-DR expression was not predictive for overall mortality, but at day 1, an HLA-DR expression of less than 14 of mean fluorescence intensity (that corresponds to 40% labeled monocytes) was predictive of mortality exclusively in patients with septic shock (odds ratio, 11.4 and 95% confidence interval, 1.7; 78.4; P < 0.008). Catecholamine infusion, mechanical ventilation, positive blood culture, and number of units of blood or plasma transfused did not correlate with decreased HLA-DR expression. Thus, the decrease in HLA-DR expression is specific to septic shock and is associated, in septic shock patients, with increased mortality risk.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 32 条
  • [1] Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis
    Bergmann, M
    Gornikiewicz, A
    Sautner, T
    Waldmann, E
    Weber, T
    Mittlböck, M
    Roth, E
    Függer, R
    [J]. SHOCK, 1999, 12 (06): : 421 - 427
  • [2] Impairment of β-adrenergic signaling in healthy peripheral blood mononuclear cells exposed to serum from patients with septic shock:: Involvement of the inhibitory pathway of adenylyl cyclase stimulation
    Bernardin, G
    Kisoka, RL
    Delporte, C
    Robberecht, P
    Vincent, JL
    [J]. SHOCK, 2003, 19 (02): : 108 - 112
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Sir Isaac Newton, sepsis, SIRS, and CARS
    Bone, RC
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (07) : 1125 - 1128
  • [5] EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units
    Brun-Buisson, C
    Meshaka, P
    Pinton, P
    Vallet, B
    Rodie-Talbere, P
    Zahar, JR
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (04) : 580 - 588
  • [6] Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation
    Brunkhorst, FM
    Clark, AL
    Forycki, ZF
    Anker, SD
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 72 (01) : 3 - 10
  • [7] Cavaillon JM, 2001, CELL MOL BIOL, V47, P695
  • [8] Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock
    Collins, JL
    Vodovotz, Y
    Hierholzer, C
    Villavicencio, RT
    Liu, SB
    Alber, S
    Gallo, D
    Stolz, DB
    Watkins, SC
    Godfrey, A
    Gooding, W
    Kelly, E
    Peitzman, AB
    Billiar, TR
    [J]. SHOCK, 2003, 19 (02): : 117 - 122
  • [9] HLA-DR expression and soluble HLA-DR levels in septic patients after trauma
    Ditschkowski, M
    Kreuzfelder, E
    Rebmann, V
    Ferencik, S
    Majetschak, M
    Schmid, EN
    Obertacke, U
    Hirche, H
    Schade, UF
    Grosse-Wilde, H
    [J]. ANNALS OF SURGERY, 1999, 229 (02) : 246 - 254
  • [10] Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment
    Docke, WD
    Randow, F
    Syrbe, U
    Krausch, D
    Asadullah, K
    Reinke, P
    VolK, HD
    Kox, W
    [J]. NATURE MEDICINE, 1997, 3 (06) : 678 - 681